SOPHiA GENETICS

SOPHiA GENETICS is a health-technology company founded in 2011 by biologists. It builds SOPHiA DDM™, an AI-driven, cloud-powered data analytics platform that distils complex multimodal data into real-time, actionable insights for clinicians, researchers and biopharma customers. The platform is used to support the diagnosis and treatment of cancer and rare inherited disorders.

The company's technical work spans artificial intelligence, cloud computing, genomics, bioinformatics and multimodal data analysis, applied to problems in precision medicine and diagnostics. The platform processes genomic and other clinical data at scale and returns interpreted results to users in near real time.

SOPHiA DDM™ is deployed across more than 800 healthcare institutions in over 70 countries, giving the company a global footprint in clinical research, oncology, rare and inherited disorders, and biopharma. The company's stated aim is to democratise data-driven medicine and to widen equitable access to precision medicine worldwide.